Purpose: To examine the response rate of gross chemo-refractory breast cancer treated with concurrent capecitabine (CAP) and radiation therapy in a prospective Phase II study. Methods and materials: Breast cancer patients with inoperable disease after chemotherapy, residual nodal disease after definitive surgical resection, unresectable chest wall or nodal recurrence after a prior mastectomy Cited by: Capecitabine (Xeloda, Hoffmann–La Roche), an oral prodrug of fluorouracil, has been shown to be efficacious as adjuvant chemotherapy in patients with gastrointestinal cancer. However, its Cited by:
May 31, · Most women in both groups received radiation, and those with hormone-sensitive breast cancer started on hormonal medications. Only one group received Xeloda, while women in the other group were. May 06, · Brand name: Xeloda Chemical name: Capecitabine Class: Antimetabolite xhustler.xyzuracil, Gemzar, and methotrexate are other antimetabolites.. How it works: Antimetabolites kill cancer cells by acting as false building blocks in a cancer cell's genes, causing the cancer cell to die as it gets ready to divide. Uses: Xeloda often is used in combination with other .
Nov 25, · I was on Xeloda more than 5 years,and with breast cancer and metastases on bones more than 9 years, without visible progresion. After progesion in tumor markers C 15 3, , scan and scintigraphy was stable, I was on Xeloda. It keep my tumor markers in normal range, and multiply metastastes on bones stable too. I had a little regesion on bones too. This supplement to ONCOLOGY includes a collection of papers focusing on the clinical development and use of capecitabine (Xeloda), a novel agent with significant activity in patients suffering from metastatic breast cancer. It is now clear that this.